A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma

Respiration

Volumn 65, Issue 4, 1998, Pages 275-281

  Nieminen, M M ^a   Vidgren, P ^b   Kokkarinen, J ^c   Laasonen, K ^a   Liippo, K ^d   Lindqvist, A ^e   Paananen, M ^f   Poukkula, A ^g   Ruotsalainen, E M ^g   Salomaa, E R ^d   Sovijarvi A ^a   Soderblom T ^e   Silvasti, M ^b   Vidgren, M ^h   Laitinen, L A ^e  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b ORION CORPORATION   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f Red Cross Private Clinic   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Asthma; Beclomethasone dipropionate; Metered dose inhaler; Multidose powder inhaler

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; HISTAMINE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PHASE 3 CLINICAL TRIAL; POWDER INHALER; PRIORITY JOURNAL; SORE THROAT; SYMPTOM; THRUSH; TIME;

EID: 0031694601     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029276     Document Type: Article

References (29)

1. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-392.
2. National Heart, Lung, and Blood Institute, National Institute of Health: International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992;5:601-641.
3. Hurter T: Asthmabronchiale und Antiasthmatika. Dtsch Apoth Z 1987;127:837-841.
4. Crompton GK: Clinical use of dry powder systems. Eur J Respir Dis 1982;63:96-99.
5. Newman SP, Miller AB, Lennard-Jones TR, Moren F, Clarke SW: Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax 1984;39:935-941.
6. Berglund E: Inhalation therapy problems and prospects. Eur Respir J 1990;3:830-832.
7. Moren F: Aerosol dosage forms and formulations; in Moren F, Newhouse MI, Dolovich M (eds): Aerosols in Medicine. Amsterdam, Elsevier, 1985, pp 262-264.
8. Pedersen S: Treatment of acute bronchoconstriction in children with use of a tube spacer aerosol and a dry powder inhaler. Allergy 1985; 40:300-304.
9. Viljanen AA, Halttunen PK, Kreus K-E, Viljanen BC: Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest 1982; 42(suppl 159):5-20.
10. Jaeschke R, Singer J, Guyatt GH: A comparison of seven-point and visual analogue scales. Control Clin Trials 1990;11:43-51.
11. Sovijärvi A, Malberg P, Reinikainen K, Rytilä P, Poppius H: A rapid dosimetric method with controlled tidal breathing for histamine challenge. Chest 1993;104:164-170.
12. Haahtela T, Vidgren M, Nyberg A, Korhonen P, Laurikainen K, Silvasti M: A novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal doses. Ann Allergy 1994;72:178-182.
13. Nieminen MM, Vidgren M, Laurikainen K, Järvinen M, Liippo K, Tammivaara R, Silvasti M: Easyhaler®, a novel multiple dose powder inhaler: Clinically equivalent to salbutamol metered dose inhaler and easier to use. Respiration 1994;61:37-41.
14. Selroos O, Pietinalho A, Löfroos A-B, Riska H: Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108: 1228-1234.
15. Newman SP: Metered dose pressurised aerosol and the ozone layer. Eur Respir J 1990;3:495-497.
16. Saunders KB: Misuse of inhaled bronchodilator agents. Br Med J 1965;1:1037-1038.
17. Coday TJ, Stewart CJ, Davies HJ: Synchronization of bronchodilator release. Practitioner 1976;217:273-275.
18. Crompton GK: Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 1982;63(suppl 119):101-104.
19. Lahdensuo A, Muittari A: Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique. Eur J Respir Dis 1986;68: 332-335.
20. Kesten S, Elias M, Cartier A, Chapman KR: Patient handling of a multidose dry powder inhalation device for albuterol. Chest 1994; 105:1077-1081.
21. Timisina MP, Martin GP, Marriot C, Ganderton D, Yianneskis M: Drug delivery to the respiratory tract using dry powder inhalers, Int J Pharm 1994;101:1-13.
22. Matthys H: Inhalation delivery of asthma drugs. Lung 1990;168(suppl):645-652.
23. Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE: Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991;87: 483-489.
24. Agertoft L, Pedersen S: Importance of the inhalation device on the effect of budesonide. Arch Dis Child 1993;69:130-133.
25. 99mTc-labelled salbutamol delivered from a novel multiple dose powder inhaler. Pharm Res 1994;11: 1320-1324.
26. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL: A comparison of fluticasone propionate 1 mg daily, with beclomethasone dipropionate, 2 mg daily in the treatment of severe asthma. Eur Respir J 1993;6:877-884.
27. Ebden P, Jenkins A, Houston G, Davies BH: Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 μg/day) and budesonide (1600 μg/ day), for chronic asthma. Thorax 1986;41:869-874.
28. Brown PH, Blundell G, Greening AP, Crompton GK: Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med 1991;85:501-510.
29. Vidgren M, Silvasti M, Vidgren P, Sormunen H, Laurikainen K, Korhonen P: Easyhaler® multidose powder inhaler - Practical and effective alternative to the pressurized MDI. Aerosol Sci Technol 1995;22:335-345.